#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CS

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Czech version

Published in: Transfuze Hematol. dnes,17, 2011, No. 4, p. 191-192.
Category: Selection of press reports and books

Labels

Haematology Internal medicine Clinical oncology

Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

Randomized, double-blind trial of fluconazole versus variconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnose AML

Treosulfan-based conditioning regiments for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria

Donor lymphocyte collections from unrelated donors of the Czech National Marrow Donors Registry (ČNMDR) between 1999 and 2010

Bone marrow microenvironment and its role in the pathogenesis of leukaemia

Serum levels of immunoglobulin free light chains in monoclonal gammopathy of undetermined significance and their contribution to stratification and monitoring

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Article was published in

Transfusion and Haematology Today

Issue 4

2011 Issue 4

Most read in this issue

Journals

#ADS_BOTTOM_SCRIPTS#